Daniel Howard

The women-only agency expands into tennis, adding Grand Slam champ Sloane Stephens and signaling a new model for athlete representation and ownership.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

As Bridgewater prepares its Q1 2026 report, investors weigh its stellar 2025 performance against new economic headwinds in the Twin Cities market.

A biotech firm is putting genetically engineered probiotics on bar menus. Is this the future of nightlife or a high-tech placebo for the mindful drinker?

With diagnostic sales fueling a diverse therapeutic arsenal, Telix reaffirms blockbuster guidance and advances pivotal trials for prostate, brain, and kidney cancers.

With the appointment of Eli Gassert as CTO, VastAdvisor signals a major push into self-learning AI, aiming to redefine how firms acquire clients.

Wisconsin's largest nonprofit hospice now serves the entire southern half of the state, bringing its patient-first model to four new counties.

voAIce's new DealerCRM, powered by OliviaAI, isn't just another tool. It's an autonomous system designed to execute sales tasks, not just track them.

A massive proptech rollout by Highmark Residential signals a new era for renters, replacing rigid schedules with on-demand, self-guided apartment tours.

Mattoboard's new AI, Design Stream, promises to end "AI slop" by generating concepts with real, sourceable products, shaking up the design industry.

A novel triple-action topical spray for male pattern baldness enters a pivotal clinical trial, potentially disrupting a multi-billion dollar market.

Sabio Holdings is merging the booming creator economy with sports, launching a new venture that could disrupt how we watch and monetize competition.

Singapore's Trident Digital faces a delisting threat from Nasdaq, raising questions about its Web 3.0 vision and the market's faith in emerging tech.

Imperial Equities' latest dividend underscores its financial health, backed by a robust Western Canadian industrial and agricultural real estate market.

A novel transdermal curcumin gel shows significant pain reduction in a clinical trial, offering a potential non-oral alternative for millions with knee pain.

The chickpea pasta pioneer is breaking its gluten-free mold, launching a wheat-based pasta with 22g of protein to win over traditional pasta lovers.

TraceGains' new Carbon Insights automates ESG compliance, giving F&B brands unprecedented ingredient-level visibility into their supply chain's carbon footprint.

Following a stunning discovery of copper, gold, and rare earths, explorers are launching a major survey to unlock the potential of Quebec's Labrador Trough.

Vlasic Labs announced its CBD products qualify for a landmark Medicare pilot. The problem? Official sources show no record of such a program existing.

VASA Fitness taps consumer brand veteran Michael Osanloo, former CEO of Portillo's, to accelerate growth in the competitive low-cost gym market.